Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease

被引:2
作者
Lozano-Sanroma, Javier [1 ]
Barros, Alberto [1 ]
Alcalde, Ignacio [1 ,2 ]
Alvarado-Villacorta, Rosa [1 ]
Sanchez-Avila, Ronald M. [3 ]
Queiruga-Pineiro, Juan [1 ]
Cueto, Luis Fernandez-Vega [1 ,2 ]
Anitua, Eduardo [3 ]
Merayo-Lloves, Jesus [1 ,2 ]
机构
[1] Inst Univ Fernandez Vega, Fdn Invest Oftalmol, Oviedo 33012, Spain
[2] Univ Oviedo, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo 33011, Spain
[3] Biotechnol Inst BTI, Regenerat Med Lab, Vitoria 01007, Spain
关键词
congenital aniridia; plasma rich in growth factors; PRGF; ocular redness; DED; OCULAR SURFACE; AUTOLOGOUS SERUM; DROPS; KERATOPATHY; MANAGEMENT; SYMPTOMS; EYEDROPS; REDNESS; INDEX; SIGNS;
D O I
10.3390/diseases12040076
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Congenital aniridia is a rare bilateral ocular malformation characterized by the partial or complete absence of the iris and is frequently associated with various anomalies, including keratopathy, cataract, glaucoma, and foveal and optic nerve hypoplasia. Additionally, nearly 50% of individuals with congenital aniridia experience symptoms of ocular dryness. Traditional treatment encompasses artificial tears and autologous serum. This study aimed to assess the effectiveness and safety of using platelet rich in growth factors (PRGF) plasma in patients with congenital aniridia and ocular dryness symptoms. Methods: The included patients underwent two cycles of a 3-month PRGF treatment. At 6 months, symptomatology was evaluated using the OSDI and SANDE questionnaires, and ocular surface parameters were analyzed. Results: The OSDI and SANDE values for frequency and severity demonstrated statistically significant improvements (p < 0.05). Ocular redness, corneal damage (corneal staining), and tear volume (Schirmer test) also exhibited statistically significant improvements (p < 0.05). No significant changes were observed in visual acuity or in the grade of meibomian gland loss. Conclusion: The use of PRGF in patients with congenital aniridia and ocular dryness symptoms led to significant improvements in symptomatology, ocular redness, and ocular damage. No adverse effects were observed during the use of PRGF.
引用
收藏
页数:14
相关论文
共 73 条
  • [1] Symptomatic dry eye treatment with autologous platelet-rich plasma
    Alio, Jorge L.
    Colecha, Jose R.
    Pastor, Silvia
    Rodriguez, Alejandra
    Artola, Alberto
    [J]. OPHTHALMIC RESEARCH, 2007, 39 (03) : 124 - 129
  • [2] The Ocular Redness Index: A Novel Automated Method for Measuring Ocular Injection
    Amparo, Francisco
    Wang, Haobing
    Emami-Naeini, Parisa
    Karimian, Parisa
    Dana, Reza
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (07) : 4821 - 4826
  • [3] Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts
    Anitua, E.
    de la Fuente, M.
    Muruzabal, F.
    Riestra, A.
    Merayo-Lloves, J.
    Orive, G.
    [J]. EXPERIMENTAL EYE RESEARCH, 2015, 135 : 118 - 126
  • [4] Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop
    Anitua, E.
    Muruzabal, F.
    De la Fuente, M.
    Merayo-Lloves, J.
    Orive, G.
    [J]. EXPERIMENTAL EYE RESEARCH, 2014, 119 : 27 - 34
  • [5] Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases
    Anitua, Eduardo
    de la Fuente, Maria
    Merayo-Lloves, Jesus
    Muruzabal, Francisco
    [J]. BIOENGINEERING-BASEL, 2022, 9 (10):
  • [6] Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies
    Anitua, Eduardo
    Muruzabal, Francisco
    Tayebba, Ali
    Riestra, Ana
    Perez, Victor L.
    Merayo-Lloves, Jesus
    Orive, Gorka
    [J]. ACTA OPHTHALMOLOGICA, 2015, 93 (08) : E605 - E614
  • [7] Plasma Rich in Growth Factors (PRGF-Endoret) Stimulates Proliferation and Migration of Primary Keratocytes and Conjunctival Fibroblasts and Inhibits and Reverts TGF-β1-Induced Myodifferentiation
    Anitua, Eduardo
    Sanchez, Mikel
    Merayo-Lloves, Jesus
    De la Fuente, Maria
    Muruzabal, Francisco
    Orive, Gorka
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (09) : 6066 - 6073
  • [8] [Anonymous], Comparison of the Healing Properties on Corneal Cells of Growth Factor-Enriched Plasma and Autologous Serum From Aniridia Patients (CICASAND)
  • [9] The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review
    Asiedu, Kofi
    Abu, Sampson Listowell
    [J]. JOURNAL OF CURRENT OPHTHALMOLOGY, 2019, 31 (01): : 8 - 15
  • [10] How much change in pain score does really matter to patients?
    Bahreini, Maryam
    Safaie, Arash
    Mirfazaelian, Hadi
    Jalili, Mohammad
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (08) : 1641 - 1646